ITI Pharma and Healthcare Fund Regular vs SBI Healthcare Opportunities Fund compare
ITI Pharma and Healthcare Fund Regular - Growth
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹221 Cr | ₹3689 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 31 Dec 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
Turn Over | % | 32% |
Expense Ratio | 2.35 | 1.94 |
Manager | Rohan Korde | Pradeep Kesavan |
ISIN Code | INF00XX01BL5 | INF200K01446 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Month | 2.05% | 2.35% |
6 Month | -5.26% | -0.84% |
1 Year | 16.48% | 20.64% |
3 Year | 23.4% | 28.76% |
5 Year | - | 23.8% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
6 Month | 5.42% | 5.47% |
1 Year | 3.19% | 9.54% |
3 Year | 22.52% | 27.14% |
5 Year | - | 22.31% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
1 Year | 20.48% | 15.53% |
3 Year | 18.71% | 17.55% |
5 Year | - | 12.71% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Standard Deviation | 15.61% | 13.97% |
Sharp | 0.93% | 1.32% |
Beta | 0.94% | 0.84% |
Alpha | -0.87% | 4.70% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Name | Rohan Korde | Pradeep Kesavan |
Total AUM | ₹4626 Cr | ₹434274 Cr |
Funds Managed | 10 | 43 |
ITI Pharma and Healthcare Fund Regular - Growth | SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 7.57 | 6.48 |
Mid Cap | 31.22 | 28.02 |
Small Cap | 32.03 | 37.63 |
Large Cap | 29.19 | 27.87 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
---|---|---|
Others | 8.42 | 1.8 |
Healthcare | 88.76 | 91.34 |
Basic Materials | 2.08 | 6.85 |
Industrials | 0.74 | - |
Financial Services | 0 | - |
Top Comparisons
HDFC Banking and Financial Services Fund - Growth Option
3Y Returns23.99%
Nippon India Banking and Financial Services Fund - Growth Plan - Growth Option
3Y Returns25.82%
Mirae Asset Equity Savings Fund- Regular Plan- Growth
3Y Returns13.14%
Baroda BNP Paribas Equity Savings Fund - Regular Plan - Growth
3Y Returns11.86%
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
3Y Returns23.25%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
3Y Returns24.56%
Aditya Birla Sun Life Bal Bhavishya Yojna Regular Growth
3Y Returns18.25%
Axis Children's Fund - Lock in - Growth
3Y Returns13.3%